Literature DB >> 20675519

Management of drooling in children.

C B R Fairhurst1, H Cockerill.   

Abstract

Drooling beyond the age of 4 years is neurodevelopmentally abnormal. Chronic "sialorrhoea" is seen in children with abnormal oral sensation and/or motor control and more infrequently when there is excessive production of saliva. Salivary production from the paired glands is under autonomic parasympathetic control. Management of the problem relies on multidisciplinary teams with a focus on assessment and when appropriate conservative interventions, oral motor training, dental appliances, medical and surgical treatment programs. Medically, the focus is on modifying the neuroglandular control of saliva with the use of anticholinergic agents. The article covers these areas of background, assessment and management in detail.

Entities:  

Mesh:

Year:  2010        PMID: 20675519     DOI: 10.1136/adc.2007.129478

Source DB:  PubMed          Journal:  Arch Dis Child Educ Pract Ed        ISSN: 1743-0585            Impact factor:   1.309


  14 in total

Review 1.  Glycopyrrolate oral solution: for chronic, severe drooling in pediatric patients with neurologic conditions.

Authors:  Karly P Garnock-Jones
Journal:  Paediatr Drugs       Date:  2012-08-01       Impact factor: 3.022

Review 2.  Nonspeech Oral Movements and Oral Motor Disorders: A Narrative Review.

Authors:  Ray D Kent
Journal:  Am J Speech Lang Pathol       Date:  2015-11       Impact factor: 2.408

3.  Anticholinergic treatment for sialorrhea in children: A systematic review.

Authors:  Peng You; Julie Strychowsky; Karan Gandhi; Breanna A Chen
Journal:  Paediatr Child Health       Date:  2021-08-27       Impact factor: 2.600

4.  Long-term follow-up of ultrasound-guided botulinum toxin-A injections for sialorrhea in neurological dysphagia.

Authors:  Pierangelo Barbero; Marco Busso; Marco Tinivella; Carlo Alberto Artusi; Stefania De Mercanti; Angele Cucci; Andrea Veltri; Paolo Avagnina; Andrea Calvo; Adriano Chio'; Luca Durelli; Marinella Clerico
Journal:  J Neurol       Date:  2015-09-26       Impact factor: 4.849

5.  The Effectiveness of Botulinum Toxin Type A Injections in the Management of Sialorrhea.

Authors:  Özgür Sürmelioğlu; Muhammed Dağkıran; Ülkü Tuncer; Süleyman Özdemir; Özgür Tarkan; Fikret Çetik; Mete Kıroğlu
Journal:  Turk Arch Otorhinolaryngol       Date:  2018-06-01

6.  Oral glycopyrrolate for the treatment of chronic severe drooling caused by neurological disorders in children.

Authors:  Marian L Evatt
Journal:  Neuropsychiatr Dis Treat       Date:  2011-09-20       Impact factor: 2.570

7.  Randomized Phase III evaluation of the efficacy and safety of a novel glycopyrrolate oral solution for the management of chronic severe drooling in children with cerebral palsy or other neurologic conditions.

Authors:  Robert S Zeller; Hak-Myung Lee; Paul F Cavanaugh; Jennifer Davidson
Journal:  Ther Clin Risk Manag       Date:  2012-01-25       Impact factor: 2.423

8.  Effect of botulinum toxin a injection into the salivary glands for sialorrhea in children with neurologic disorders.

Authors:  In Seuk Jeung; Soyoung Lee; Heung Sik Kim; Chang Ki Yeo
Journal:  Ann Rehabil Med       Date:  2012-06-30

Review 9.  Sialorrhea: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins.

Authors:  Amanda Amrita Lakraj; Narges Moghimi; Bahman Jabbari
Journal:  Toxins (Basel)       Date:  2013-05-21       Impact factor: 4.546

10.  The drooling reduction intervention trial (DRI): a single blind trial comparing the efficacy of glycopyrronium and hyoscine on drooling in children with neurodisability.

Authors:  Jeremy R Parr; Emma Weldon; Lindsay Pennington; Nick Steen; Jane Williams; Charlie Fairhurst; Anne O'Hare; Raj Lodh; Allan Colver
Journal:  Trials       Date:  2014-02-17       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.